Skip to content

Effect of wild mint on oligomenorrhea

Assessment of effect of wild mint product on oligo/Amenorrhea by Viewpoints of traditional Iranian medicine

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201110027690N1
Enrollment
120
Registered
2011-12-09
Start date
2011-10-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oligomenorrhea. Secondary oligomenorrhoea

Interventions

Intervention 1: Syrup of wild mint, 3 times each day, each time 15 cc, 3 cycles of menstruation. Intervention 2: Syrup of glucose, 3 times each day, each time 15cc, 3 cycles of menstruation.
Treatment - Drugs
Placebo
Syrup of wild mint, 3 times each day, each time 15 cc, 3 cycles of menstruation
Syrup of glucose, 3 times each day, each time 15cc, 3 cycles of menstruation

Sponsors

Shahed University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patient satisfaction; Outpatients aged between18-35 years; More than two months of oligomenorrhea; Negative pregnancy test; Not breastfeeding; Patient's hormones (TSH, FSH, PRL) not higher than normal; No Hormonal treatment (chemical or plant) is allowed at the same time; No malignancies; No chronic kidney disease and liver disease; Stress is not one of the reason for delayed menstruation. Exclusion criteria: Patients that use hormone therapy; Patients who experienced side effects; Patients who need surgery and other interventions; Patients with a personal decision to exit from the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Start of bleeding. Timepoint: Before intervention and 1, 2 & 3 months later. Method of measurement: Question.;FSH. Timepoint: Beginning & end of study. Method of measurement: ELISA.;LH. Timepoint: Beginning & end of study. Method of measurement: ELISA.;Testosterone. Timepoint: Beginning & end of study. Method of measurement: ELISA.;Free testosterone. Timepoint: Beginning & end of study. Method of measurement: ELISA.

Secondary

MeasureTime frame
Side effects. Timepoint: During the study. Method of measurement: Question.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRoshanak Mokaberinejad

Shahed University

mokaberi@shshed.ac.ir , Rmokaberi@gmail.com+98 21 2288 2521

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026